Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: AEHA) is a clinical-stage biopharmaceutical company that completed its business combination with Aesther Healthcare Acquisition Corp in February 2023, with Aesther Healthcare Sponsor LLC serving as the SPAC's sponsor. Aesther Healthcare Acquisition Corp completed its IPO in 2021, targeting opportunities in the healthcare and life sciences sector. The combined company, focused on developing treatments across oncology, fibrosis, pulmonary arterial hypertension, and infectious disease, filed its first 10-K as a public entity on March 31, 2023, covering the period ended December 31, 2022. Visit SpacDesk and sign up for full data, filings history, and deal analytics on AEHA and hundreds of other SPAC transactions.